{"id":40007,"date":"2017-07-28T07:09:36","date_gmt":"2017-07-28T11:09:36","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=40007"},"modified":"2017-07-28T01:10:53","modified_gmt":"2017-07-28T05:10:53","slug":"novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007","title":{"rendered":"Novogen Limited (ADR) (NASDAQ:NVGN) And Pacific Biosciences To Manufacture And Co-Market Novel Applications"},"content":{"rendered":"<p>The stock of <strong>Novogen Limited (ADR) <\/strong><strong>(NASDAQ:NVGN) <\/strong>closed at 3.36 gaining 6.20% in yesterday&#8217;s trading session. Over the years, the top provider has been offering genomic services and solutions. Today it has made the much awaited announcement. It has disclosed that it will be collaborating with <strong>Pacific Biosciences of California (NASDAQ:PACB).<\/strong>The two will set out in a joint move to develop and promote novel applications. These will of course be based on the PacBio\u00ae Sequel\u00ae System.<\/p>\n<p>According to some top trusted sources, the new applications\u00a0that they will be coming up with under this particular consensus will be for a common course. The two will be focusing on both the translational and the basic research in the field of precision medicine. They will concentrate on sample processing,\u00a0automation,\u00a0workflow, database construction and algorithm development.<\/p>\n<p>Real-Time (SMRT\u00ae) technology is associated with a uniform coverage\u00a0and that is of course across the various genome regions, including low-diversity and palindromes\u00a0regions of the genome.<\/p>\n<p>Experts affirm that the Genome sequencing with PacBio Systems plays a major role in the delivery of more accurate and complete views of all\u00a0of all forms of genomic variation. It is thus possible to observe SNPs\/SNVs, mobile elements,\u00a0structural variants,\u00a0haplotypes,\u00a0epigenetics, and variants in low-complexity regions.<\/p>\n<p>The same experts move further to reveal that the Sequel System together with the isoform sequencing (Iso-Seq\u00ae) method help generate full-length cDNA sequences. These are later used in the profiling of the full complexity of the human transcriptome. Technological advancements are moving the world pretty fast. Some time back, it would have been impossible to discover novel genes, gene fusion events and isoforms.<\/p>\n<p>Novogene according to some trusted sources has the capacity to run up to 10 PacBio Sequel Systems. Over the years it has based its operations in an enormous facility for SMRT Sequencing in a single location.<\/p>\n<p>One of the company\u2019s top officials while recently addressing a number of news reports <a href=\"https:\/\/finance.yahoo.com\/news\/novogene-pacific-biosciences-jointly-develop-120000126.html\" target=\"_blank\" rel=\"noopener\">opined<\/a>, \u201cNovogene has extensive expertise in developing and marketing high-quality end-to-end service solutions, from sample preparation to data analysis.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The stock of Novogen Limited (ADR) (NASDAQ:NVGN) closed at 3.36 gaining 6.20% in yesterday&#8217;s trading session. Over the years, the top provider has been offering [&hellip;]<\/p>\n","protected":false},"author":13,"featured_media":40016,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[2459,3666,7420,2458,3665,3664],"stock_ticker":[],"class_list":["post-40007","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-nasdaqnvgn","tag-nasdaqpacb","tag-novogen-limited-adr","tag-novogen-limited-adr-nasdaqnvgn","tag-pacific-biosciences-of-california","tag-pacific-biosciences-of-california-nasdaqpacb","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Novogen Limited (ADR) (NASDAQ:NVGN) And Pacific Biosciences To Manufacture And Co-Market Novel Applications - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novogen Limited (ADR) (NASDAQ:NVGN) And Pacific Biosciences To Manufacture And Co-Market Novel Applications - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"The stock of Novogen Limited (ADR) (NASDAQ:NVGN) closed at 3.36 gaining 6.20% in yesterday&#8217;s trading session. Over the years, the top provider has been offering [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-07-28T11:09:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/07\/40015-images.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"277\" \/>\n\t<meta property=\"og:image:height\" content=\"182\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lisa Ray\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lisa Ray\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007\"},\"author\":{\"name\":\"Lisa Ray\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c\"},\"headline\":\"Novogen Limited (ADR) (NASDAQ:NVGN) And Pacific Biosciences To Manufacture And Co-Market Novel Applications\",\"datePublished\":\"2017-07-28T11:09:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007\"},\"wordCount\":357,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/07\/40015-images.jpeg\",\"keywords\":[\"NASDAQ:NVGN\",\"NASDAQ:PACB\",\"Novogen Limited (ADR)\",\"Novogen Limited ADR (NASDAQ:NVGN)\",\"Pacific Biosciences of California\",\"Pacific Biosciences of California (NASDAQ:PACB)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007\",\"name\":\"Novogen Limited (ADR) (NASDAQ:NVGN) And Pacific Biosciences To Manufacture And Co-Market Novel Applications - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/07\/40015-images.jpeg\",\"datePublished\":\"2017-07-28T11:09:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/07\/40015-images.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/07\/40015-images.jpeg\",\"width\":277,\"height\":182},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novogen Limited (ADR) (NASDAQ:NVGN) And Pacific Biosciences To Manufacture And Co-Market Novel Applications\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c\",\"name\":\"Lisa Ray\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png\",\"caption\":\"Lisa Ray\"},\"description\":\"Lisa has a Bachelor of Arts in journalism from Purdue University and 3 years of experience in the publishing field.\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/linsay-thomas\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Novogen Limited (ADR) (NASDAQ:NVGN) And Pacific Biosciences To Manufacture And Co-Market Novel Applications - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007","og_locale":"en_US","og_type":"article","og_title":"Novogen Limited (ADR) (NASDAQ:NVGN) And Pacific Biosciences To Manufacture And Co-Market Novel Applications - Wall Street PR","og_description":"The stock of Novogen Limited (ADR) (NASDAQ:NVGN) closed at 3.36 gaining 6.20% in yesterday&#8217;s trading session. Over the years, the top provider has been offering [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2017-07-28T11:09:36+00:00","og_image":[{"width":277,"height":182,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/07\/40015-images.jpeg","type":"image\/jpeg"}],"author":"Lisa Ray","twitter_misc":{"Written by":"Lisa Ray","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007"},"author":{"name":"Lisa Ray","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c"},"headline":"Novogen Limited (ADR) (NASDAQ:NVGN) And Pacific Biosciences To Manufacture And Co-Market Novel Applications","datePublished":"2017-07-28T11:09:36+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007"},"wordCount":357,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/07\/40015-images.jpeg","keywords":["NASDAQ:NVGN","NASDAQ:PACB","Novogen Limited (ADR)","Novogen Limited ADR (NASDAQ:NVGN)","Pacific Biosciences of California","Pacific Biosciences of California (NASDAQ:PACB)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007","url":"https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007","name":"Novogen Limited (ADR) (NASDAQ:NVGN) And Pacific Biosciences To Manufacture And Co-Market Novel Applications - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/07\/40015-images.jpeg","datePublished":"2017-07-28T11:09:36+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/07\/40015-images.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/07\/40015-images.jpeg","width":277,"height":182},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novogen-limited-adr-nasdaqnvgn-and-pacific-biosciences-to-manufacture-and-co-market-novel-applications-40007#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Novogen Limited (ADR) (NASDAQ:NVGN) And Pacific Biosciences To Manufacture And Co-Market Novel Applications"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c","name":"Lisa Ray","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png","caption":"Lisa Ray"},"description":"Lisa has a Bachelor of Arts in journalism from Purdue University and 3 years of experience in the publishing field.","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/linsay-thomas"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/40007","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=40007"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/40007\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/40016"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=40007"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=40007"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=40007"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=40007"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}